Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER

Open-label extensions [studies SP516 (NCT00501969) and SP715 (NCT00594386)] of the CLEOPATRA-PD and PREFER studies were conducted to evaluate the safety, tolerability and efficacy of the dopaminergic agonist, rotigotine, over several years of follow-up in patients with advanced Parkinson’s disease (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Neural Transmission 2013-07, Vol.120 (7), p.1069-1081
Hauptverfasser:	LeWitt, Peter A., Boroojerdi, Babak, Surmann, Erwin, Poewe, Werner
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Administration, Cutaneous Adult Aged Aged, 80 and over Dopamine Agonists - administration & dosage Double-Blind Method Female Humans Longitudinal Studies Male Medicine Medicine & Public Health Middle Aged Neurology Neurology and Preclinical Neurological Studies - Original Neurology and Preclinical Neurological Studies - Original Article Neurosciences Outcome Assessment, Health Care Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - psychology Psychiatry Severity of Illness Index Tetrahydronaphthalenes - administration & dosage Thiophenes - administration & dosage Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!